Another recent preclinical study explored the potential of regulating the NF-κB pathway through microalgal carotenoids, including astaxanthin, fucoxanthin, and zeaxanthin, as a therapeutic approach for melanoma. The gene discussed is NFKB1; the disease is melanoma.